ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business trends

No lab monkey? Japan Inc waits eagerly for China goods to return

Earnings downgrades look inevitable for many companies

A monkey cloned from a gene-edited macaque with circadian rhythm disorders is seen in a lab at the Institute of Neuroscience of Chinese Academy of Sciences in Shanghai.   © Reuters
BUMPEI MATSUKAWA, Nikkei staff writer | Japan

TOKYO -- Trans Genic, a gene analysis company that carries out preclinical trials for pharmaceutical companies, has downgraded its fiscal 2019 earnings due to the coronavirust epidemic in China. 

The company has been unable to import lab monkeys from China it uses for contract trials due to customs restrictions following the outbreak. 

Read Next

Latest On Business trends

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close